Announcement

Collapse
No announcement yet.

Infect Disord Drug Targets . COVID-19 Treatment Success After Repeat Courses of Azithromycin: a report of three cases

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Infect Disord Drug Targets . COVID-19 Treatment Success After Repeat Courses of Azithromycin: a report of three cases


    Infect Disord Drug Targets


    . 2020 Nov 26.
    doi: 10.2174/1871526520999201126203510. Online ahead of print.
    COVID-19 Treatment Success After Repeat Courses of Azithromycin: a report of three cases


    Fereshteh Ghiasvand 1 , Maryam Ghadimi 2 , Sara Sadr 3 , Fatemeh Jafari 4 , Navid Manafi 4 , Zahra Ah-Madinejad 1 , Samaneh Tirgar 5 , Seyed Ahmad Seyed Alinaghi 6



    Affiliations

    Abstract

    Azithromycin has been considered as a possible therapeutic agent for COVID-19 patients. However, there is lim-ited data on its efficacy. We describe three patients diagnosed with COVID-19 who did not respond to the initial treatment but improved dramatically upon adding azithromycin with a successful outcome.

    Keywords: Atazanavir; Azithromycin; Coronavirus disease 2019 (COVID-19); Hydroxychloroquine; Ritonavir; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

Working...
X